LAGUNA HILLS, Calif., March 14, 2016 – /Globe Newswire/ — Sonendo® Inc., the developer of a transformative technology for root canal therapy, announced today the launch of a patient-based website with the goal of helping patients make more informed decisions when considering root canal therapy.
The GentleWave® System facilitates a one-treatment root canal procedure and has the ability to outperform the clinical results obtained with conventional procedures which can leave as much as 40% of treated root canals with bacteria1-4. Research on the many patient-facing benefits of the GentleWave difference, such as, the ability to deliver a higher standard of clean than may be achieved with conventional therapy and patient testimonials regarding their GentleWave experience, can be found at www.gentlewave.com.
Chris Rabbitt, Chief Commercial Officer, stated, “We look forward to helping patients make informed decisions about their options when needing dental care. When considering root canal therapy, patients seek optimal outcomes that will quickly alleviate their pain and lead to saving their natural teeth with minimal disruption to their quality of life. Ultimately, we believe the GentleWave procedure aligns with these patient-centered goals and delivers on our mission of “Saving Teeth Through Sound Science®.”
You can find more information on their company website www.sonendo.com.
1Haapasalo M et al. (2014) J Endod. 40:1178-81. 2 Molina B et al. (2015) J Endod. 41:1701-05. 3Siqueira JF Jr. et al. (1997) Int Endod J. 30:279-82. 4Sjögren U et al. (1997) Int Endod J. 30:297-306.
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science®. The first commercially available product from Sonendo, the GentleWave® System, available in the US, shows significant improvements in clinical efficacy and treatment efficiency when compared to conventional root canal techniques1-2. For more information please visit: www.sonendo.com.
1Haapasalo M et al. (2014) J Endod. 40:1178-81. 2 Molina B et al. (2015) J Endod. 41:1701-05.
This announcement contains forward-looking statements that are based on management's beliefs, assumptions and expectations and on information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.